APA (7th ed.) Citation

Martinon-Torres, F., Wysocki, J., Szenborn, L., Carmona-Martinez, A., Poder, A., Dagan, R., . . . Kaminski, J. (2023). A Phase III, multicenter, randomized, double-blind, active comparator-controlled study to evaluate the safety, tolerability, and immunogenicity of V114 compared with PCV13 in healthy infants (PNEU-PED-EU-1). Vaccine, 41(21), 3387. https://doi.org/10.1016/j.vaccine.2023.04.036

Chicago Style (17th ed.) Citation

Martinon-Torres, Federico, et al. "A Phase III, Multicenter, Randomized, Double-blind, Active Comparator-controlled Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 Compared with PCV13 in Healthy Infants (PNEU-PED-EU-1)." Vaccine 41, no. 21 (2023): 3387. https://doi.org/10.1016/j.vaccine.2023.04.036.

MLA (9th ed.) Citation

Martinon-Torres, Federico, et al. "A Phase III, Multicenter, Randomized, Double-blind, Active Comparator-controlled Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 Compared with PCV13 in Healthy Infants (PNEU-PED-EU-1)." Vaccine, vol. 41, no. 21, 2023, p. 3387, https://doi.org/10.1016/j.vaccine.2023.04.036.